JN.1 Variant Alert: Pakistan's Precarious Healthcare System under Intense Scrutiny
DOI:
https://doi.org/10.51985/JBUMDC2024323Abstract
The recent COVID-19 variant, JN 1, identified by the World Health Organization, is considered a notable strain stemming from the OMICRON subvariant BA.2.86. Despite its unique spike protein mutation (S:L455S), JN.1 is anticipated to have minimal impact on global public health. The singular modification in the virus's spike protein, distinguishing JN.1 from BA.2.86, suggests that existing vaccines should effectively counter both variants. The World Health Organization emphasizes the continued efficacy of current vaccines in protecting against diseases and deaths caused by JN.1, urging individuals, especially those at high risk, to maintain updated vaccinations
References
Looi MK. Covid-19: WHO adds JN.1 as new variant of
interest. BMJ. 2023 Dec 21;p2975.
Altamimi I, Alabdulkarim I, Alhumimidi A, Albabtain M,
Temsah MH. Navigating Novel Uncertainties of COVID-19:
The Rise of the JN.1 Variant. Cureus. 2024 Feb;16.
Junaidi I. Health ministry “fully alert” as 15 cases of JN.1
Covid variant confirmed countrywide [Internet]. DAWN.COM.
[cited 2024 Feb 2]. Available from: https://www.dawn.
com/news/1806261
Akhtar H, Afridi M, Akhtar S, Ahmad H, Ali S, Khalid S, et
al. Pakistan’s Response to COVID-19: Overcoming National
and International Hypes to Fight the Pandemic. JMIR Public
Health Surveill. 2021 May 19;7(5):e28517.
Saad Zaidi SM. COVID-19: Exacerbating Pakistan’s economic
problems – a critical analysis using the dependency paradigm.
Asian Journal of Comparative Politics. 2023 Dec
;8(4):811–24.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Kanza Mehmood, Maryam Moazzam, Minahil Fatima Sajid
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0